HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy.

AbstractBACKGROUND & AIMS:
Photodynamic therapy (PDT) is a technique for nonsurgical treatment of patients with dysplasia in Barrett's esophagus. The primary endpoint for PDT has been resolution of dysplasia. We studied the effect of PDT at the genetic level.
METHODS:
Archival material from 3 patients who had initial improvement in dysplasia after PDT but occurrence of high-grade dysplasia during follow-up was used. Biopsy specimens were analyzed for increased proliferation, aneuploidy, p53 protein overexpression, p53 mutations, and p16 promoter hypermethylation.
RESULTS:
Patients developed high-grade dysplasia 16, 28, and 37 months after PDT. In all cases, one or more genetic markers were positive after PDT treatment, whereas histology was downstaged consistently after therapy. Increasing genetic abnormalities were noted by the end of follow-up.
CONCLUSIONS:
Genetic abnormalities may persist after PDT despite phenotypical improvement of dysplasia. These patients may progress to high-grade dysplasia or develop adenocarcinoma. Histologic improvement in dysplasia is an inadequate endpoint for PDT in patients with Barrett's esophagus.
AuthorsK K Krishnadath, K K Wang, K Taniguchi, T J Sebo, N S Buttar, M A Anderson, L S Lutzke, W Liu
JournalGastroenterology (Gastroenterology) Vol. 119 Issue 3 Pg. 624-30 (Sep 2000) ISSN: 0016-5085 [Print] United States
PMID10982754 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cyclin-Dependent Kinase Inhibitor p16
  • Tumor Suppressor Protein p53
Topics
  • Aged
  • Aneuploidy
  • Barrett Esophagus (drug therapy, genetics, metabolism, pathology)
  • Cyclin-Dependent Kinase Inhibitor p16 (genetics, metabolism)
  • Esophagus (pathology)
  • Follow-Up Studies
  • Humans
  • Male
  • Methylation
  • Middle Aged
  • Photochemotherapy
  • Point Mutation (genetics)
  • Promoter Regions, Genetic
  • Tumor Suppressor Protein p53 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: